MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PTGX made $56,368K in revenue. $3,783K in net income. Net profit margin of 6.71%.

Income Overview

Revenue
$56,368K
Net Income
$3,783K
Net Profit Margin
6.71%
EPS
$0.05
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
License and collaboration revenue
56,368 7,437 4,712 5,546
Research and development
46,739 46,358 40,003 37,036
General and administrative
13,277 11,434 11,130 10,551
Total operating expenses
60,016 57,792 51,133 47,587
Loss from operations
-3,648 -50,355 -46,421 -42,041
Interest income
5,876 6,761 7,049 7,406
Other income, net
53 -124 33 36
Income (loss) before income tax benefit
2,281 -43,718 -39,339 -34,599
Income tax benefit
-1,502 666 -172
Net income (loss)
3,783 -44,384 -39,339 -34,771
Basic EPS
0.06 -0.693 -0.62 -0.55
Diluted EPS
0.05 -0.693 -0.62 -0.55
Basic Average Shares
65,087,847 64,045,517 63,772,332 63,510,537
Diluted Average Shares
70,492,618 64,045,517 63,772,332 63,510,537
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$5,876K (-22.41%↓ Y/Y)Other income, net$53K (-35.37%↓ Y/Y)Income (loss) beforeincome tax benefit$2,281K (119.57%↑ Y/Y)Income tax benefit-$1,502K Loss from operations-$3,648K (81.11%↑ Y/Y)License andcollaboration revenue$56,368K (99.03%↑ Y/Y)Net income (loss)$3,783K (132.46%↑ Y/Y)Total operatingexpenses$60,016K (26.00%↑ Y/Y)Research and development$46,739K (30.22%↑ Y/Y)General andadministrative$13,277K (13.11%↑ Y/Y)

Protagonist Therapeutics, Inc (PTGX)

Protagonist Therapeutics, Inc (PTGX)